Estudio farmacoeconómico de lopinavir/ritonavir en monoterapia en el ensayo clínico OK04-Reference-Cited by-同舟云学术

Estudio farmacoeconómico de lopinavir/ritonavir en monoterapia en el ensayo clínico OK04

Published:2011-09 Issue:3 Volume:8 Page:85-98
ISSN:1695-405X
Container-title:PharmacoEconomics Spanish Research Articles
language:es
Short-container-title:Pharmacoecon. Span. Res. Artic.

Author:

Arribas José R.,Pulido Federico,Lázaro Pablo,Méndez Ignacio

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/BF03320891.pdf

Reference40 articles.

1. WHO. Las 10 causas principales de defunción [The 10 leading causes of death]. Descriptive note no 310. October 2008 [website]. WHO; 2009 [accessed 27 April 2009]. Available at: http://www.who.int/mediacentre/factsheets/fs310/es/print.html .

2. WHO. Acceso universal para 2010 [Universal access by 2010] [website]. WHO; 2009 [accessed 27 April 2009]. Available at: http://www.who.int/hiv/universalaccess2010/es/index.html

3. Palella F, Delaney K, Moorman A, et al. Declining morbidity and mortality among subjects with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853–60.

4. Falco V, Rodriguez D, Ribera E, et al. Severe nucleosideassociated lactic acidosis in human immunodeficiency virusinfected patients: report of 12 cases and review of the literature. Clin Infect Dis 2002;34:838–46.

5. Van der Valk M, Gisolf EH, Reiss P, et al. Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV infection. AIDS 2001;15:847–55

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential for simplification of HIV treatment with boosted protease inhibitor monotherapy;International Journal of Clinical Pharmacy;2012-09-25